When is targeted therapy recommended for melanoma?

Targeted medicines act on a particular protein or pathway involved in melanoma cells. They are not selected from the appearance of a mole alone. The team considers the biopsy diagnosis, stage, whether the melanoma can be removed, molecular test results, previous treatment, other health conditions, and the balance of benefits and possible harms. A matching molecular result does not by itself determine the whole plan; surgery, immunotherapy, monitoring, or another approach may also be discussed.

Ask the oncology team whether tumour tissue has been tested and what the result means for your melanoma. Bring a complete medicine list, including supplements, and mention heart, liver, kidney, eye, or neurologic conditions. Before starting, ask how the medicine is taken, which monitoring visits or blood tests are needed, and what to do if a dose is missed. Keep a record of new symptoms rather than stopping treatment without guidance.

Contact the oncology team promptly for a new widespread rash, severe diarrhoea, yellowing of the eyes or skin, dark urine, unusual bleeding, marked weakness, breathing trouble, chest pain, confusion, or a severe headache. Urgent symptoms need medical attention even if the treatment is expected to help the melanoma. Use the emergency service for severe breathing difficulty, fainting, or sudden neurologic changes.

What molecular change was found, and is it actionable with this medicine? What is the goal in my stage of melanoma? How will you monitor my skin, blood tests, and organs? Which symptoms require a same-day call, and what alternatives exist if this treatment is unsuitable?